4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0001104659-22-061591
10% owner sold 418,738 shares at an average $9.66 ($4,045,791)
From the SEC's structured data for this filing
Trades in this filing
F2 Vision SCS · 10% owner
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-05-12 | Sale : show line 1 in the form | −264,072 | $9.25 | $2,442,587 | 1,460,539 | D |
| 2022-05-13 | Sale : show line 2 in the form | −85,319 | $9.96 | $850,042 | 1,375,220 | D |
| 2022-05-13 | Sale : show line 3 in the form | −34,189 | $10.48 | $358,335 | 1,341,031 | D |
| 2022-05-16 | Sale : show line 4 in the form | −35,158 | $11.23 | $394,828 | 1,305,873 | D |
| Open-market sales · 418,738 sh · avg $9.66 · $4,045,791 | ||||||
Loading xslF345X03/tm2215669-1_4seq1.xml…